https://www.prnewswire.com/news-releases/shiratronics-completes-enrollment-in-reliev-cm2-pivotal-trial-of-implantable-extracranial-neuromodulation-systems-iens-for-chronic-migraine-302787346.html

ShiraTronics Completes Enrollment in RELIEV-CM2 Pivotal Trial of Implantable Extracranial Neuromodulation Systems (IENs) for Chronic Migraine